Literature DB >> 36008615

The crucial roles of long noncoding RNA SNHGs in lung cancer.

Feng Chen1,2, Fa Zhang3, Yu-Fang Leng4, Ya-Jing Shi1, Jian-Ming Zhang1, Yong-Qiang Liu1.   

Abstract

Lung cancer is one of the most common malignant tumors with growing morbidity and mortality worldwide. Several treatments are used to manage lung cancer, including surgery, radiotherapy and chemotherapy, as well as molecular-targeted therapy. However, the current measures are still far from satisfactory. Therefore, the current research should focus on exploring the molecular mechanism and then finding an effective treatment. Interestingly, we and others have embarked on a line of investigations focused on the mechanism of lung cancer. Specifically, lncRNA small nucleolar RNA host gene has been shown to be associated with biological characteristics and therapeutic resistance of lung cancer. In addition, small nucleolar RNA host genes may be used as diagnostic biomarker in the future. Herein, we will provide a brief review demonstrating the importance of small nucleolar RNA host genes in lung cancer, especially non-small cell lung cancer. Although lncRNA has shown a crucial role in tumor-related research, a large number of studies are needed to validate its clinical application in the future.
© 2022. The Author(s), under exclusive licence to Federación de Sociedades Españolas de Oncología (FESEO).

Entities:  

Keywords:  Biological characteristics; Lung cancer; Small nucleolar RNA host genes; Therapeutic target; lncRNA

Mesh:

Substances:

Year:  2022        PMID: 36008615     DOI: 10.1007/s12094-022-02909-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.340


  92 in total

Review 1.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

Review 2.  Pathology of lung cancer.

Authors:  William D Travis
Journal:  Clin Chest Med       Date:  2002-03       Impact factor: 2.878

Review 3.  ALK inhibitors in non-small cell lung cancer: the latest evidence and developments.

Authors:  Ivana Sullivan; David Planchard
Journal:  Ther Adv Med Oncol       Date:  2016-01       Impact factor: 8.168

4.  Cancer Statistics, 2021.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2021-01-12       Impact factor: 508.702

Review 5.  Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors.

Authors:  Mahaveer Singh; Hemant R Jadhav
Journal:  Drug Discov Today       Date:  2017-10-12       Impact factor: 7.851

6.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

7.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 8.  Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer.

Authors:  Thomas K Sin; Fengfeng Wang; Fei Meng; S C Cesar Wong; William C S Cho; Parco M Siu; Lawrence W C Chan; Benjamin Y M Yung
Journal:  Int J Mol Sci       Date:  2016-02-15       Impact factor: 5.923

9.  Long non-coding MELTF Antisense RNA 1 promotes and prognosis the progression of non-small cell lung cancer by targeting miR-1299.

Authors:  Jin Chai; Li Qin; Guangxin Zhang; Peiyan Hua; Chengyan Jin
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

10.  Poor prognosis of intra-tumoural TRBV6-6 variants in EGFR-mutant NSCLC: Results from the ADJUVANT-CTONG1104 trial.

Authors:  Cunte Chen; Siyang Maggie Liu; Yedan Chen; Ming Han; Qiuxiang Ou; Hua Bao; Ling Xu; Yikai Zhang; Jia-Tao Zhang; Wenzhao Zhong; Qing Zhou; Xue-Ning Yang; Yang Shao; Yi-Long Wu; Si-Yang Liu; Yangqiu Li
Journal:  Clin Transl Med       Date:  2022-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.